"Unveiling Immune System's Hidden Potential: Scientists Uncover Surprising Defense Mechanisms and Cell Killers"
Scientists have developed a new method using bispecific single-domain antibodies, called BiCEs, to activate the complement system and target cancer cells more effectively. By linking a complement protein and a specific protein on the cancer cell surface, the BiCE molecules can activate the complement system, leading to the specific killing of cancer cells. This innovative approach has the potential to revolutionize cancer immunotherapy by engaging more of the body's immune response and could be translated into clinical applications.